메뉴 건너뛰기




Volumn 29, Issue 24, 2011, Pages 3224-3231

High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: Overview of six randomized trials

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; HORMONE RECEPTOR; IFOSFAMIDE; MELPHALAN; METHOTREXATE; MITOXANTRONE;

EID: 80052018701     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.5936     Document Type: Article
Times cited : (69)

References (28)
  • 1
    • 78049485263 scopus 로고    scopus 로고
    • Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    • Ferlay J., Shin H.R., Bray F., et al: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917, 2010
    • (2010) Int J Cancer , vol.127 , pp. 2893-2917
    • Ferlay, J.1    Shin, H.R.2    Bray, F.3
  • 2
    • 79959990351 scopus 로고    scopus 로고
    • (ed 2). Atlanta, GA, American Cancer Society
    • American Cancer Society: Global Cancer Facts & Figures (ed 2). Atlanta, GA, American Cancer Society, 2011. http://www.cancer.org/acs/groups/ content/@epidemiologysurveilance/documents/document/acspc-027766.pdf
    • (2011) Global Cancer Facts & Figures
  • 3
    • 0018931869 scopus 로고
    • Dose: A critical factor in cancer chemotherapy
    • Frei E. 3rd, Canellos G.P.: Dose: A critical factor in cancer chemotherapy. Am J Med 69:585-594, 1980
    • (1980) Am J Med , vol.69 , pp. 585-594
    • Frei III, E.1    Canellos, G.P.2
  • 4
    • 0021744793 scopus 로고
    • The importance of dose intensity in chemotherapy of metastatic breast cancer
    • Hryniuk W., Bush H.: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2:1281-1288, 1984 (Pubitemid 15202705)
    • (1984) Journal of Clinical Oncology , vol.2 , Issue.11 , pp. 1281-1288
    • Hryniuk, W.1    Bush, H.2
  • 5
    • 0026558969 scopus 로고
    • A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy
    • Antman K., Ayash L., Elias A., et al: A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol 10:102-110, 1992
    • (1992) J Clin Oncol , vol.10 , pp. 102-110
    • Antman, K.1    Ayash, L.2    Elias, A.3
  • 7
    • 0027057246 scopus 로고
    • High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: Follow-up report
    • Williams S.F., Gilewski T., Mick R., et al: Highdose consolidation therapy with autologous stemcell rescue in stage IV breast cancer: Follow-up report. J Clin Oncol 10:1743-1747, 1992 (Pubitemid 23059951)
    • (1992) Journal of Clinical Oncology , vol.10 , Issue.11 , pp. 1743-1747
    • Williams, S.F.1    Gilewski, T.2    Mick, R.3    Bitran, J.D.4
  • 9
    • 4243753888 scopus 로고    scopus 로고
    • Superiority of tandem high-dose chemotherapy (HDC) versus optimized conventionally-dosed chemotherapy (CDC) in patients (pts) with metastatic breast cancer (MBC): The International Randomized Breast Cancer Dose Intensity Study (IBDIS I)
    • abstr 88
    • Crown J., Perey L., Lind M., et al: Superiority of tandem high-dose chemotherapy (HDC) versus optimized conventionally-dosed chemotherapy (CDC) in patients (pts) with metastatic breast cancer (MBC): The International Randomized Breast Cancer Dose Intensity Study (IBDIS I). Proc Am Soc Clin Oncol 22, 2003 (abstr 88). http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst - detail-view&confID=23&abstractID=103811
    • (2003) Proc Am Soc Clin Oncol , vol.22
    • Crown, J.1    Perey, L.2    Lind, M.3
  • 10
    • 0035366299 scopus 로고    scopus 로고
    • An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publications
    • Weiss R.B., Gill G.G., Hudis C.A.: An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publications. J Clin Oncol 19:2771-2777, 2001 (Pubitemid 32538184)
    • (2001) Journal of Clinical Oncology , vol.19 , Issue.11 , pp. 2771-2777
    • Weiss, R.B.1    Gill, G.G.2    Hudis, C.A.3
  • 12
    • 4243878700 scopus 로고    scopus 로고
    • A randomized trial of high-dose chemotherapy (HDC) with autologous peripheral blood stem cell support (ASCT) compared to standard therapy in women with metastatic breast cancer: A National Cancer Institute of Canada (NCIC) Clinical Trials Group Study
    • abstr 82
    • Crump M., Gluck S., Stewart D., et al: A randomized trial of high-dose chemotherapy (HDC) with autologous peripheral blood stem cell support (ASCT) compared to standard therapy in women with metastatic breast cancer: A National Cancer Institute of Canada (NCIC) Clinical Trials Group Study. Proc Am Soc Clin Oncol 20, 2001 (abstr 82). http://www.asco.org/ASCOv2/Meetings/Abstracts? &vmview=abst-detail-view&confID=10&abstractID=82
    • (2001) Proc Am Soc Clin Oncol , vol.20
    • Crump, M.1    Gluck, S.2    Stewart, D.3
  • 13
    • 84921702226 scopus 로고    scopus 로고
    • High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy forwomenwith metastatic breast cancer
    • CD003142
    • Farquhar C., Marjoribanks J., Basser R., et al: High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy forwomenwith metastatic breast cancer. Cochrane Database Syst Rev 1:CD003142, 2003
    • (2003) Cochrane Database Syst Rev , vol.1
    • Farquhar, C.1    Marjoribanks, J.2    Basser, R.3
  • 14
    • 32944471342 scopus 로고    scopus 로고
    • High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer
    • CD003142
    • Farquhar C., Marjoribanks J., Basser R., et al: High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer. Cochrane Database Syst Rev 3:CD003142, 2005
    • (2005) Cochrane Database Syst Rev , vol.3
    • Farquhar, C.1    Marjoribanks, J.2    Basser, R.3
  • 15
    • 0037286183 scopus 로고    scopus 로고
    • High-dose chemotherapy for breast cancer: The French PEGASE experience
    • Roché H., Viens P., Biron P., et al: High-dose chemotherapy for breast cancer: The French PEGASE experience. Cancer Control 10:42-47, 2003 (Pubitemid 36231961)
    • (2003) Cancer Control , vol.10 , Issue.1 , pp. 42-47
    • Roche, H.1    Viens, P.2    Biron, P.3    Lotz, J.-P.4    Asselain, B.5
  • 19
    • 0031720392 scopus 로고    scopus 로고
    • A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: Summation dose-intensity
    • Hryniuk W., Frei E. 3rd, Wright F.A.: A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: Summation doseintensity. J Clin Oncol 16:3137-3147, 1998 (Pubitemid 28417437)
    • (1998) Journal of Clinical Oncology , vol.16 , Issue.9 , pp. 3137-3147
    • Hryniuk, W.1    Frei III, E.2    Wright, F.A.3
  • 20
    • 0037532157 scopus 로고    scopus 로고
    • Conventional-dose chemotherapy compared with highdose chemotherapy (HDC) plus autologous stem-cell transplantation (SCT) for metastatic breast cancer: 5-Year update of the 'Philadelphia Trial' (PBT-1)
    • abstr 169
    • Stadtmauer E.A., O'Neill A., Goldstein L.J., et al: Conventional-dose chemotherapy compared with highdose chemotherapy (HDC) plus autologous stem-cell transplantation (SCT) for metastatic breast cancer: 5-year update of the 'Philadelphia Trial' (PBT-1). Proc Am Soc Clin Oncol 21, 2002 (abstr 169). http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst-detail- view&confID=16&abstractID=169
    • (2002) Proc Am Soc Clin Oncol , vol.21
    • Stadtmauer, E.A.1    O'Neill, A.2    Goldstein, L.J.3
  • 21
    • 41549148282 scopus 로고    scopus 로고
    • Pegase 03: A prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer
    • DOI 10.1038/sj.bmt.1705935, PII 1705935
    • Biron P., Durand M., Roché H., et al: Pegase 03: A prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer. Bone Marrow Transplant 41:555-562, 2008 (Pubitemid 351472147)
    • (2008) Bone Marrow Transplantation , vol.41 , Issue.6 , pp. 555-562
    • Biron, P.1    Durand, M.2    Roche, H.3    Delozier, T.4    Battista, C.5    Fargeot, P.6    Spaeth, D.7    Bachelot, T.8    Poiget, E.9    Monnot, F.10    Tanguy, M.L.11    Cure, H.12
  • 22
    • 37849033195 scopus 로고    scopus 로고
    • Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16
    • Crump M., Gluck S., Tu D., et al: Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16. J Clin Oncol 26:37-43, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 37-43
    • Crump, M.1    Gluck, S.2    Tu, D.3
  • 23
    • 80052016382 scopus 로고    scopus 로고
    • Highdose chemotherapy (HDC) produces a superior rate of durable complete remission (DCR) compared to conventional chemotherapy in metastatic breast cancer (MBC): Mature results of the International Breast Cancer Dose-Intensity Study
    • suppl 3; abstr 1020
    • Crown J.P., Leyvraz S., Verrill M., et al: Highdose chemotherapy (HDC) produces a superior rate of durable complete remission (DCR) compared to conventional chemotherapy in metastatic breast cancer (MBC): Mature results of the International Breast Cancer Dose-Intensity Study. Ann Oncol 15:iii27, 2004 (suppl 3; abstr 1020)
    • (2004) Ann Oncol , vol.15
    • Crown, J.P.1    Leyvraz, S.2    Verrill, M.3
  • 24
    • 33646773983 scopus 로고    scopus 로고
    • High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: A therapy whose time has passed
    • Vogl D.T., Stadtmauer E.A.: High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: A therapy whose time has passed. Bone Marrow Transplant 37:985-987, 2006
    • (2006) Bone Marrow Transplant , vol.37 , pp. 985-987
    • Vogl, D.T.1    Stadtmauer, E.A.2
  • 25
    • 11144318239 scopus 로고    scopus 로고
    • Is high-dose chemotherapy dead?
    • Rodenhuis S.: Is high-dose chemotherapy dead? Eur J Cancer 41:9-11, 2005
    • (2005) Eur J Cancer , vol.41 , pp. 9-11
    • Rodenhuis, S.1
  • 26
    • 71549143528 scopus 로고    scopus 로고
    • Detecting an overall survival benefit that is derived from progression-free survival
    • Broglio K.R., Berry D.A.: Detecting an overall survival benefit that is derived from progression-free survival. J Natl Cancer Inst 101:1642-1649, 2009
    • (2009) J Natl Cancer Inst , vol.101 , pp. 1642-1649
    • Broglio, K.R.1    Berry, D.A.2
  • 28
    • 80051991350 scopus 로고    scopus 로고
    • High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: Overview of 15 randomized trials
    • Berry D.A., Ueno N.T., Johnson M.M., et al: High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: Overview of 15 randomized trials. J Clin Oncol 29:3214-3223, 2011
    • (2011) J Clin Oncol , vol.29 , pp. 3214-3223
    • Berry, D.A.1    Ueno, N.T.2    Johnson, M.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.